NO991292D0 - Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser - Google Patents

Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser

Info

Publication number
NO991292D0
NO991292D0 NO991292A NO991292A NO991292D0 NO 991292 D0 NO991292 D0 NO 991292D0 NO 991292 A NO991292 A NO 991292A NO 991292 A NO991292 A NO 991292A NO 991292 D0 NO991292 D0 NO 991292D0
Authority
NO
Norway
Prior art keywords
benzopyranols
neurological disorders
treat neurological
treat
disorders
Prior art date
Application number
NO991292A
Other languages
English (en)
Norwegian (no)
Other versions
NO991292L (no
Inventor
Andrew A Parsons
Mervyn Thompson
Neil Upton
John Morris Evans
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO991292L publication Critical patent/NO991292L/no
Publication of NO991292D0 publication Critical patent/NO991292D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
NO991292A 1996-09-18 1999-03-17 Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser NO991292D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9619492.3A GB9619492D0 (en) 1996-09-18 1996-09-18 Novel treatment
PCT/EP1997/005168 WO1998011890A1 (fr) 1996-09-18 1997-09-15 Utilisation de benzopyranol dans le traitement d'affections neurologiques

Publications (2)

Publication Number Publication Date
NO991292L NO991292L (no) 1999-03-17
NO991292D0 true NO991292D0 (no) 1999-03-17

Family

ID=10800127

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991292A NO991292D0 (no) 1996-09-18 1999-03-17 Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser

Country Status (30)

Country Link
EP (1) EP0939630B1 (fr)
JP (1) JP2001500520A (fr)
KR (1) KR20000036184A (fr)
CN (1) CN1230885A (fr)
AP (1) AP9901473A0 (fr)
AR (1) AR008838A1 (fr)
AT (1) ATE270102T1 (fr)
AU (1) AU730465B2 (fr)
BG (1) BG103252A (fr)
BR (1) BR9712030A (fr)
CA (1) CA2266681A1 (fr)
DE (1) DE69729735T2 (fr)
DZ (1) DZ2311A1 (fr)
EA (1) EA199900306A1 (fr)
ES (1) ES2223075T3 (fr)
GB (1) GB9619492D0 (fr)
HU (1) HUP9904638A3 (fr)
ID (2) ID23175A (fr)
IL (1) IL128786A0 (fr)
MA (1) MA24321A1 (fr)
NO (1) NO991292D0 (fr)
NZ (1) NZ334271A (fr)
OA (1) OA10998A (fr)
PE (1) PE109898A1 (fr)
PL (1) PL332313A1 (fr)
SK (1) SK35199A3 (fr)
TR (1) TR199900527T2 (fr)
UY (1) UY24717A1 (fr)
WO (1) WO1998011890A1 (fr)
ZA (1) ZA978359B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US20130281524A1 (en) * 2008-06-05 2013-10-24 Peter Blower Novel treatments
MX2010013312A (es) * 2008-06-05 2011-05-30 Minster Res Ltd Tratamientos novedoos.
ES2642586T3 (es) 2009-07-27 2017-11-16 Gilead Sciences, Inc. Compuestos heterocíclicos condensados como moduladores de canales iónicos
US20130018091A1 (en) * 2009-12-03 2013-01-17 Peter Blower Treatment of allodynia and hyperalgesia
EP2506847A1 (fr) * 2009-12-03 2012-10-10 Proximagen Limited Traitement de maladies infectieuses
EP2588197B1 (fr) 2010-07-02 2014-11-05 Gilead Sciences, Inc. Composés hétérocycliques condensés en tant que modulateurs des canaux ioniques
KR20140033377A (ko) 2011-05-10 2014-03-18 길리애드 사이언시즈, 인코포레이티드 나트륨 채널 조절제로서의 융합된 헤테로시클릭 화합물
NO3175985T3 (fr) 2011-07-01 2018-04-28
UY34171A (es) 2011-07-01 2013-01-31 Gilead Sciences Inc Compuestos heterocíclicos fusionados como moduladores del canal iónico
CN106397317B (zh) * 2016-09-26 2019-03-22 天津师范大学 1,2,3,4-四氢喹啉化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
US5510375A (en) * 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
CN1174975C (zh) * 1994-06-10 2004-11-10 史密丝克莱恩比彻姆有限公司 苯并吡喃类化合物和它们作为治疗剂的用途
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
EP0939630A1 (fr) 1999-09-08
AR008838A1 (es) 2000-02-23
AU730465B2 (en) 2001-03-08
BG103252A (en) 1999-09-30
DZ2311A1 (fr) 2002-12-28
HUP9904638A2 (hu) 2001-05-28
JP2001500520A (ja) 2001-01-16
EA199900306A1 (ru) 1999-08-26
PL332313A1 (en) 1999-08-30
SK35199A3 (en) 2000-07-11
MA24321A1 (fr) 1998-04-01
ATE270102T1 (de) 2004-07-15
CA2266681A1 (fr) 1998-03-26
ZA978359B (en) 1999-03-17
UY24717A1 (es) 2001-08-27
HUP9904638A3 (en) 2001-08-28
AU4704797A (en) 1998-04-14
PE109898A1 (es) 1999-03-21
BR9712030A (pt) 1999-08-24
KR20000036184A (ko) 2000-06-26
CN1230885A (zh) 1999-10-06
AP9901473A0 (en) 1999-03-31
TR199900527T2 (xx) 1999-06-21
EP0939630B1 (fr) 2004-06-30
ES2223075T3 (es) 2005-02-16
NO991292L (no) 1999-03-17
WO1998011890A1 (fr) 1998-03-26
GB9619492D0 (en) 1996-10-30
ID23175A (id) 2000-03-23
DE69729735T2 (de) 2005-07-14
ID19542A (id) 1998-07-23
DE69729735D1 (de) 2004-08-05
NZ334271A (en) 2001-03-30
OA10998A (en) 2003-03-04
IL128786A0 (en) 2000-01-31

Similar Documents

Publication Publication Date Title
EE04280B1 (et) Imidasopürimidiinid ja imidasopüridiinid neuroloogiliste häirete käitlemiseks
ATE365042T1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
IL112603A0 (en) Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
DE69822638D1 (de) Heterocyclische vinylether zur behandlung neurologischer krankheiten
DE69925571D1 (de) Sulphonamid-derivate zur behandlung von störungen des zentralnervensystems
AUPM864894A0 (en) Treatment of bowel-dependent neurological disorders
IS5113A (is) Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana
NO993051L (no) Intranasale formuleringer for behandling av seksuelle forstyrrelser
NO991292D0 (no) Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO995231D0 (no) Terapeutisk behandling av hudlidelser
EE200000391A (et) Triasiiniühendid kesknärvisüsteemihäirete raviks
PL345110A1 (en) Aza-heterocyclic compounds used to treat neurological disorders and hair loss
GB9926968D0 (en) Treatment of neurological disorders
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
ATE256126T1 (de) 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
ATE190486T1 (de) Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen
NO974569L (no) Benzamider for behandling av neurodegenerative forstyrrelser
NO20010390D0 (no) Behandling av angstsykdommer
NO976024D0 (no) Anvendelse av N-cykloheksylbenzamider for å behandle tarmlidelser
HUP9902167A3 (en) Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system
NO994526L (no) Fremgangsmaate for stimulering av neural regenerering
ATE204167T1 (de) Antikonvulsive derivate zur behandlung von psoriasis
ZA9610134B (en) The use of 1-hydroxy-2-pyridones for the treatment of mucosal disorders which are difficult to treat
HK1022628A (en) Use of benzopyranols to treat neurological disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application